Open AccessA Novel Anti-Cd40 Monoclonal Antibody, Iscalimab, for Control of Graves’ Hyperthyroidism – A Proof-Of-Concept Trial
Author(s) -
George J. Kahaly,
Marius N. Stan,
Lara Frommer,
P Gergely,
Laurence Colin,
Ahmed Amer,
Imelda Schuhmann,
Pascal Espié,
James S. Rush,
Craig T. Basson,
Y L He
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jcemdgz013
Subject(s) - medicine , autoantibody , thyroid peroxidase , graves' disease , context (archaeology) , endocrinology , cd40 , thyroid , gastroenterology , antibody , immunology , chemistry , paleontology , biology , biochemistry , cytotoxic t cell , in vitro
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom